Adelaide University researchers have found that semaglutide, the active ingredient in Ozempic and Wegovy, significantly reduces blood flow to the uterus and oxygen levels to the foetus in pregnant sheep. The study used MRI scans to measure maternal heart function and found cardiovascular output decreased within two hours of drug administration. While manufacturers recommend stopping the medications three months before conceiving, a recent poll reveals more than half of GPs have had patients conceal their use of these weight loss drugs during pregnancy.
Subscribe and set 🔔 » https://7news.link/YTSubscribe |
For the latest Australian news and breaking news alerts, connect with 7NEWS online:
Visit » https://7news.com.au
7Plus » https://7plus.com.au/
7NEWS Podcast » https://open.spotify.com/user/dm9fk9hzoe68ibpttheragdgi
Facebook » https://www.facebook.com/7NewsAustralia
TikTok » https://www.tiktok.com/@7newsaustralia
Instagram » https://www.instagram.com/7newsaustralia/
X » https://x.com/7NewsAustralia
7NEWS combines the trusted and powerful news brands including Sunrise, The Morning Show, Spotlight and 7NEWS.com.au, delivering unique, engaging and continuous coverage on the issues that matter most to Australians. Watch 7 News Australia full broadcasts and full episodes at 6pm and weekdays at 12pm and 4pm on Channel 7 and 7plus.
#BREAKINGNEWS #7NEWS
